Edition:
United Kingdom

Allogene Therapeutics Inc (ALLO.OQ)

ALLO.OQ on NASDAQ Stock Exchange Global Select Market

26.27USD
16 Aug 2019
Change (% chg)

$-0.04 (-0.15%)
Prev Close
$26.31
Open
$26.50
Day's High
$26.76
Day's Low
$26.06
Volume
190,134
Avg. Vol
162,674
52-wk High
$35.55
52-wk Low
$21.67

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Jun '19 0.00 -0.413
Mar '19 0.00 -0.325
FY 2018 Dec '18 0.00 -0.251
Sep '18 0.00 -0.377
Jun '18 0.00 -1.193
Mar '18 0.00 -0.099
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 12 0.00 0.00 0.00 --
Quarter Ending Dec-19 12 0.00 0.00 0.00 --
Year Ending Dec-19 12 0.00 0.00 0.00 --
Year Ending Dec-20 12 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Sep-19 11 -0.54 -0.44 -0.61 --
Quarter Ending Dec-19 11 -0.66 -0.47 -0.74 --
Year Ending Dec-19 11 -1.94 -1.61 -2.06 --
Year Ending Dec-20 12 -2.46 -1.71 -3.31 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 18.57 19.25
P/E High - Last 5 Yrs. -- 227.41 23.82
P/E Low - Last 5 Yrs. -- 21.11 11.63
Beta -- 1.29 1.43
Price to Sales (TTM) -- 63.90 5.92
Price to Book (MRQ) -- 0.68 2.78
Price to Tangible Book (MRQ) -- 0.98 2.86
Price to Cash Flow (TTM) -- 15.46 22.86
% Owned Institutions -- 0.57 0.64

Dividends

  Company industry sector
Dividend Yield -- 2.22 1.93
Dividend Yield - 5 Year Avg -- 2.12 2.02
Dividend 5 Year Growth Rate -- 8.77 20.70
Payout Ratio(TTM) -- 18.45 18.80

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 204.49 16.39
Sales (TTM) vs TTM 1 Yr. Ago -- 64.18 10.68
Sales - 5 Yr. Growth Rate -- 13.82 13.80
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 34.82 36.71
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 7.93 10.44
Capital Spending - 5 Yr. Growth Rate -- 18.81 18.40

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 0.41 0.04
Current Ratio (MRQ) -- 1.86 1.50
LT Debt to Equity (MRQ) -- 731.70 32.08
Total Debt to Equity (MRQ) -- 890.73 68.89
Interest Coverage (TTM) -- 19.09 12.49

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 28.70 3.21
Gross Margin - 5 Yr. Avg. -- 36.95 2.87
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 31.40 48.22
Operating Margin (TTM) -- 22.70 36.93
Operating Margin - 5 Yr. Avg. -- 25.43 40.92
Pre-Tax Margin (TTM) -- 19.80 37.40
Pre-Tax Margin - 5 Yr. Avg. -- 22.12 41.37
Net Profit Margin (TTM) -- 14.68 29.95
Net Profit Margin - 5 Yr. Avg. -- 16.45 32.82
Effective Tax Rate (TTM) -- 22.17 21.01
Effective Tax Rate - 5 Yr. Avg. -- 25.46 20.79

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 124,753,383 52,826,674
Net Income/Employee (TTM) -- 13,617,277 18,989,373
Receivable Turnover (TTM) -- 523.76 12,088.39
Inventory Turnover (TTM) -- 56.33 1.22
Asset Turnover (TTM) -- 0.11 0.02

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 0.89 2.62
Return on Assets - 5 Yr. Avg. -- 1.61 2.81
Return on Investment (TTM) -- 1.49 0.44
Return on Investment - 5 Yr. Avg. -- 2.47 0.44
Return on Equity (TTM) -- 5.90 15.61
Return on Equity - 5 Yr. Avg. -- 10.52 19.79

Performance for Allogene Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -- -- -- 61
13 Week -- -- -- 61
26 Week -- -- -- 50
52 Week -- -- -- 53
YTD -- -- -- 59
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 56.91%
# of Holders: 152
Total Shares Held: 69,291,006
3 Mo. Net Change: 3,229,491
# New Positions: 37
# Closed Positions: 17
# Increased Positions: 99
# Reduced Positions: 42
# Net Buyers: 57
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.